Skip to main content
Roger Li, MD, Urology, Tampa, FL

RogerLiMD

Urology Tampa, FL

Minimally Invasive Surgery, Surgical Oncology

H. Lee Moffitt Cancer Center

Dr. Li is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Li's full profile

Already have an account?

  • Office

    12902 Magnolia Drive
    Tampa, FL 33612
    Phone+1 813-745-8343
    Fax+1 813-449-6828

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2016 - 2018
  • Loma Linda University Health Education Consortium
    Loma Linda University Health Education ConsortiumResidency, Urology, 2010 - 2016
  • Loma Linda University Health Education Consortium
    Loma Linda University Health Education ConsortiumResidency, Surgery, 2010 - 2012
  • University of California, Irvine, School of Medicine
    University of California, Irvine, School of MedicineClass of 2010
  • University of California, Los Angeles
    University of California, Los AngelesB.S., Biochemistry, Magna Cum Laude, 2002 - 2006

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2018 - 2026
  • CA State Medical License
    CA State Medical License 2011 - 2019
  • TX State Medical License
    TX State Medical License 2016 - 2018
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Junior Faculty Research Award Moffitt Cancer Center, 2022
  • SITC Travel Award SITC, 2020
  • European Urology Oncology Top Reviewer, 2019-2020
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • High-frequency dusting versus conventional holmium laser lithotripsy for intrarenal and ureteric calculi  
    Li R, Ruckle D, Keheila M, Maldonado J, Lightfoot M, Alsyouf M, Yeo A, Abourbih SA, Olgin G, Arenas JL, Baldwin DD, J Endourol, 1/13/2016
  • Current technique and results for extended pelvic lymph node dissection during robot-assisted radical prostatectomy  
    Li R, Petros FG, Kukreja JB, Williams SB, Davis JW, Investig Clin Urol, 1/1/2016
  • Bench-top feasibility testing of a novel percutaneous renal access technique: the laser direct alignment radiation reduction technique (DARRT)  
    Khater N, Shen JK, Arenas JL, Keheila M, Alsyouf M, Martin JA, Lightfoot MA, Li R, Olgin Gaudencio, Smith JC, Baldwin DD, J Endourol, 1/1/2016
  • Join now to see all

Abstracts/Posters

  • Salvage intravesical Mycobaterium phlei cell wall-nucleic acid complex (MCNA) for BCG-unresponsive patients
    Li R, Amehin J, Cohen Z, Champagne M, Kamat AM, SUO, San Antonio, TX, 1/1/2016
  • Salvage intravesical Mycobaterium phlei cell wall-nucleic acid complex (MCNA) for BCG-unresponsive patients
    Li R, Amehin J, Cohen Z, Champagne M, Kamat AM, SITC, National Harbor, MD, 1/1/2016
  • The Implementation of a Perioperative Surgical Home Is Associated with Decreased Postoperative Length of Stay and Cost: A Pilot Study
    Cheriyan S, Shen J, Hu B, Stier G, Myklak K, Belay R, Li R, Baldwin DD, Ruckle HC, AUA, San Diego, CA, 1/1/2016
  • Join now to see all

Lectures

  • Costmetic Impact of Port Versus Portless Needlescopic Surgery – A Prospective, Rnadomized, Single-Blinded Study 
    New Orleans, LA - 1/1/2015
  • The Efficacy of Conventional and Stone Dusting Settings in Calyceal and Ureteral Calculi 
    Loma Linda, CA - 1/1/2014
  • How a Donor Nephrectomy Population can Help Clarify Warm Renal Ischemia Effects During Partial Nephrectomy 
    Taipei, Taiwan - 1/1/2014
  • Join now to see all

Press Mentions

  • En Bloc vs Standard Resection Found to Lower Bladder Cancer Recurrence Rate
    En Bloc vs Standard Resection Found to Lower Bladder Cancer Recurrence RateMay 22nd, 2023
  • 'Fantastic,' 'Terrific' Results with Oncolytic Virus Combo for Bladder Cancer
    'Fantastic,' 'Terrific' Results with Oncolytic Virus Combo for Bladder CancerMay 1st, 2023
  • Identifying Actionable Genetic Alterations in Metastatic Urothelial Carcinoma
    Identifying Actionable Genetic Alterations in Metastatic Urothelial CarcinomaNovember 23rd, 2021
  • Join now to see all